Anavex: Understanding Their Alzheimer's Open-Label Extension Data Skeptically #Anavex #Understanding #Alzheimer039s #OpenLabel #Extension #Data #Skeptically
Tag: OpenLabel
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension…